broncasma berna

polyvalent antigen vaccine containing 8 types of bacteria or their autolysates which are commonly detected during upper respiratory tract infections

Networked: 12 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Nakatani, M: 1 article (08/2001)

Related Diseases

1.	Tonsillitis 04/01/1993 - "The treatment of recurrent tonsillitis with Broncasma Berna instead of tonsillectomy." 01/01/1998 - "All of the 82 patients, who were aged between 5 and 67 years and who suffered from recurrent tonsillitis, were given an injection of a bacterial vaccine (Broncasma Berna, Swiss Serum Institute, Berne) that has been used in many countries for three decades. "
2.	Asthma (Bronchial Asthma) 03/24/1973 - "[Effect of Broncasma Berna on bronchial asthma. " 09/01/1970 - "[Evaluation of Broncasma berna therapy in bronchial asthma by double blind test]."
3.	Stupor 03/01/1986 - "Correlation between antitumor activity and effects on some biological properties, such as phagocytic activity of the reticuloendothelial system, the third component of complement (C3) activation, hepatic drug-metabolizing activities and pentobarbital-induced narcosis, of antitumor agents from various natural sources such as B B (Broncasma Berna), GU-P (Grifora umbellata polysaccharide), OK-432, PS-K (Polysaccharide Kureha), and RA-P (Rumex acetosa polysaccharide) were studied with female ICR mice implanted with Sarcoma 180 solid tumor. "
4.	Sinusitis 01/01/1982 - "Effects of Broncasma Berna on chronic sinusitis and nasal allergy." 01/01/1982 - "Broncasma Berna because of its non-specific desensitization effect has value as the drug of preference in treating nasal allergy cases where a specific antigen can not be found, and chronic sinusitis with a convoluted chronic course, especially where the involvement of infectious allergy is suspected."
5.	Sarcoma 180 03/01/1986 - "Correlation between antitumor activity and effects on some biological properties, such as phagocytic activity of the reticuloendothelial system, the third component of complement (C3) activation, hepatic drug-metabolizing activities and pentobarbital-induced narcosis, of antitumor agents from various natural sources such as B B (Broncasma Berna), GU-P (Grifora umbellata polysaccharide), OK-432, PS-K (Polysaccharide Kureha), and RA-P (Rumex acetosa polysaccharide) were studied with female ICR mice implanted with Sarcoma 180 solid tumor. "

Related Drugs and Biologics

1.	Bacterial Vaccines
2.	Bacterial Antigens
3.	Vaccines
4.	Polysaccharides (Glycans)
5.	Picibanil
6.	Pentobarbital (Nembutal)
7.	Irritants (Vesicants)
8.	Complement C3 (C3 Complement)
9.	Antineoplastic Agents (Antineoplastics)
10.	Antigens

Related Therapies and Procedures

1.	Immunotherapy
2.	Pleurodesis
3.	Tonsillectomy
4.	Therapeutics